PTPRZ1
Basic information
Region (hg38): 7:121873089-122062036
Previous symbols: [ "PTPZ", "PTPRZ" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPRZ1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 98 | 106 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 99 | 10 | 6 |
Variants in PTPRZ1
This is a list of pathogenic ClinVar variants found in the PTPRZ1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-121968054-T-A | not specified | Uncertain significance (Jun 05, 2024) | ||
7-121968055-C-A | not specified | Uncertain significance (May 02, 2024) | ||
7-121968055-C-T | not specified | Uncertain significance (Jul 16, 2021) | ||
7-121968064-C-A | not specified | Uncertain significance (Dec 02, 2022) | ||
7-121972594-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
7-121972670-A-C | not specified | Uncertain significance (Aug 20, 2024) | ||
7-121976195-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
7-121976220-A-C | not specified | Uncertain significance (Feb 21, 2024) | ||
7-121976266-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
7-121976277-T-C | Likely benign (Dec 31, 2019) | |||
7-121976791-A-G | not specified | Uncertain significance (Jun 26, 2024) | ||
7-121976833-G-A | not specified | Uncertain significance (Dec 03, 2021) | ||
7-121983708-G-T | Uncertain significance (-) | |||
7-121984017-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
7-121984068-T-C | Benign (Nov 26, 2018) | |||
7-121996396-C-G | not specified | Uncertain significance (Apr 18, 2023) | ||
7-121996478-T-C | not specified | Uncertain significance (Oct 10, 2023) | ||
7-121996492-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
7-121996535-A-G | not specified | Uncertain significance (Oct 05, 2021) | ||
7-121996551-T-C | Likely benign (Apr 06, 2018) | |||
7-121997893-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
7-121997985-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
7-121997991-C-A | not specified | Uncertain significance (Jul 09, 2024) | ||
7-122004612-AGAACTT-A | Spastic paraparesis | Uncertain significance (Jan 19, 2018) | ||
7-122004617-T-A | not specified | Uncertain significance (May 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTPRZ1 | protein_coding | protein_coding | ENST00000393386 | 30 | 188948 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.990 | 0.0100 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.853 | 1103 | 1.19e+3 | 0.930 | 0.0000578 | 15222 |
Missense in Polyphen | 224 | 305.24 | 0.73384 | 4004 | ||
Synonymous | 1.05 | 417 | 445 | 0.937 | 0.0000235 | 4534 |
Loss of Function | 7.22 | 18 | 93.2 | 0.193 | 0.00000442 | 1227 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.0000997 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000930 | 0.0000924 |
European (Non-Finnish) | 0.0000798 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Protein tyrosine phosphatase that negatively regulates oligodendrocyte precursor proliferation in the embryonic spinal cord. Required for normal differentiation of the precursor cells into mature, fully myelinating oligodendrocytes. May play a role in protecting oligondendrocytes against apoptosis. May play a role in the establishment of contextual memory, probably via the dephosphorylation of proteins that are part of important signaling cascades (By similarity). {ECO:0000250}.;
- Pathway
- Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human);Spinal Cord Injury;VEGFA-VEGFR2 Signaling Pathway;Other interleukin signaling;Signaling by Interleukins;Cytokine Signaling in Immune system;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.274
Intolerance Scores
- loftool
- 0.535
- rvis_EVS
- -2.22
- rvis_percentile_EVS
- 1.35
Haploinsufficiency Scores
- pHI
- 0.418
- hipred
- Y
- hipred_score
- 0.651
- ghis
- 0.580
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.584
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Ptprz1
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- hematopoietic progenitor cell differentiation;protein dephosphorylation;axonogenesis;central nervous system development;learning or memory;cytokine-mediated signaling pathway;peptidyl-tyrosine dephosphorylation;oligodendrocyte differentiation;regulation of oligodendrocyte progenitor proliferation
- Cellular component
- plasma membrane;integral component of plasma membrane;intrinsic component of plasma membrane;synapse;perineuronal net
- Molecular function
- protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding